The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Safety results from a prospective study of concurrent radiosurgery and bevacizumab for recurrent malignant glioma.
K. C. Cuneo
No relevant relationships to disclose
A. R. Cabrera
Honoraria - BrainLAB; Varian Medical Systems
Research Funding - Genentech; Varian Medical Systems
J. H. Sampson
No relevant relationships to disclose
K. J. Allen
No relevant relationships to disclose
J. J. Vredenburgh
Consultant or Advisory Role - Genentech
Honoraria - Genentech
K. Peters
No relevant relationships to disclose
Z. Chang
No relevant relationships to disclose
J. E. Herndon
No relevant relationships to disclose
A. Desjardins
No relevant relationships to disclose
D. A. Reardon
Consultant or Advisory Role - Genentech; Merck
Honoraria - Genentech; Merck
J. Kirkpatrick
Honoraria - BrainLAB; Varian Medical Systems
Research Funding - BrainLAB; Genentech